Loomis, Sayles & Company’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
GKIM
Loomis, Sayles & Company's HALO Position: Q2 2023 in Review
Loomis, Sayles & Company sold out of Halozyme (HALO) in Q2 2023, closing a stake of 2,129,204 shares — an estimated $81.3M sold.
Loomis, Sayles & Company first reported a position in HALO in Q3 2019 and held it in 15 quarters. The position peaked at $121M in Q4 2022. 370 funds tracked by Wall St. Rank hold HALO as of Q2 2023.
- Loomis, Sayles & Company reported no remaining Halozyme position as of Q2 2023 after selling out during the quarter.
- Loomis, Sayles & Company sold 2,129,204 Halozyme shares in Q2 2023, an estimated $81.3M.
- Loomis, Sayles & Company first reported a position in Halozyme in Q3 2019 and held it in 15 quarters.
- Loomis, Sayles & Company's Halozyme position peaked at $121M in Q4 2022.
- 370 funds tracked by Wall St. Rank held Halozyme as of Q2 2023.
Based on Loomis, Sayles & Company's 13F filing for Q2 2023, filed 11 Aug 2023.